Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13vPnC vs 7vPnC in Healthy Infants in Italy
NCT00366899Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2006
- Primary completion
- Jul 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Prevnar 13 in pneumococcal disease, sponsored by Pfizer. Started Oct 2006; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT00366899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366899.